Ifakara Health Institute   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Ifakara Tanzania, United Republic of (1956)

Organization Overview

First Clinical Trial
2000
NCT00140361
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2025

Timeline

NOW
  • Now

Alternative names

Ifakara Health Institute | Ifakara Health Institute Clinical Trial Facility, Bagamoyo Research and Training Centre, PO Box 74, Bagamoyo, Tanzania | Ifakara Health Institute (IHI) | Ifakara Health Institute (IHI), Bagamoyo, Tanzania | Ifakara Health Institute (IHI), Tanzania | Ifakara Health Research and Development Centre | Ifakara Health Research & Development Centre, Tanzania

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 3)

Anemia, Iron-Deficiency (Phase 3)

Deficiency Diseases (Phase 3)

Infections (Phase 1)

Malaria (Phase 4)

Malaria, Falciparum (Phase 4)

Rabies (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 32
  • # of Trial APIs: 38